The 12 closest competitors and alternatives to Expedition Medicines among biotech companies — ranked by similarity to what Expedition Medicines actually does, not by market-cap band.
Subscribe to see Expedition Medicines’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Expedition Medicines is a biotech company headquartered in United States. Xcout tracks 19 named people at Expedition Medicines, including Molly Gibson (Chief Executive Officer | Co-Founder).
13 more named people on record for Expedition Medicines, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to Expedition Medicines by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Similar biotech company
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Similar biotech company
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Biotechnology
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Biotechnology
Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.
Similar biotech company
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Biotechnology
ProFound Therapeutics is a biotechnology company founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Headquartered in Cambridge, Massachusetts, the company is pioneering the exploration of the expanded human proteome.
Similar biotech company
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Similar biotech company
Aikium is a biotechnology company headquartered in Berkeley, California, that integrates deep learning with ultra-large-scale wet lab experimentation to advance protein therapeutics.
Biotechnology
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Biotechnology
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Expedition Medicinesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →